공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 당생물학(Glycobiology) 시장 예측, 경쟁 동향, 성장 기회(-2025년) : 제품, 용도, 최종사용자, 지역별

Global Glycobiology Market, By Product, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2021년 01월 상품 코드 979730
페이지 정보 영문 224 Pages
가격
US $ 4,450 ₩ 4,953,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,066,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,518,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 당생물학(Glycobiology) 시장 예측, 경쟁 동향, 성장 기회(-2025년) : 제품, 용도, 최종사용자, 지역별 Global Glycobiology Market, By Product, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2021년 01월 페이지 정보 : 영문 224 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 당생물학(Glycobiology) 시장 규모는 2019년 9억 3,876만 달러에서 예측기간 중 13.83%의 연평균 복합 성장률(CAGR)로 확대될 전망입니다. 암, 당뇨병, 신장질환 등 만성질환 증가, 맞춤형 의료 수요, Drug Discovery 프로세스 증가, 신흥국가에서의 R&D 활동에 대한 다양한 정부 보조금 등의 요인이 시장 성장을 가속하고 있습니다. 당생물학 연구 증가, 기술 진보, 정부 이니셔티브 증가 또한 시장 성장을 가속할 전망입니다.

세계의 당생물학(Glycobiology)(Glycobiology) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 세계 및 지역/국가별 시장 규모, 시장 점유율 추이와 예측, 제품·용도·최종사용자·용도 등 각종 구분별 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

제1장 제품 개요

제2장 조사 방법

제3장 COVID-19의 영향

제4장 고객의 견해

제5장 개요

제6장 세계 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품별
    • 효소
    • 기기
    • 시약
    • 키트
  • 용도별
    • Drug Discovery
    • 질환 진단
    • 바이러스
    • 세포생물학
    • 종양
    • 기타
  • 최종사용자별
    • 연구기관
    • 진단센터
    • 병원
    • 임상 실험실
    • 제약 기업/바이오테크놀러지 기업
    • 기타
  • 기업별
  • 지역별
  • 제품 시장 맵

제7장 북미 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품별
  • 응용
  • 최종사용자별
  • 국가별
  • 국가별 분석

제8장 유럽 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품별
  • 응용
  • 최종사용자별
  • 국가별
  • 국가별 분석

제9장 아시아태평양 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품별
  • 응용
  • 최종사용자별
  • 국가별
  • 국가별 분석

제10장 남미 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품별
  • 응용
  • 최종사용자별
  • 국가별
  • 국가별 분석

제11장 중동 및 아프리카 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품별
  • 응용
  • 최종사용자별
  • 국가별
  • 국가별 분석

제12장 시장 역학

  • 촉진요인
  • 과제

제13장 시장 동향

제14장 경쟁 구도

  • Merck & Co., Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • New England Biolabs, Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Waters Corporation
  • Asparia Glycomics S.L.
  • Bruker Corporation
  • RayBiotech, Inc.
  • Z Biotech, LLC.
  • Chemily Glycoscience
  • Dextra Laboratories Ltd.
  • Lectenz Bio
  • Ludger Ltd
  • R&D Systems, Inc.
  • Glycotope GmbH
  • Danaher Corporation
  • S-BIO
  • Bio-Rad Laboratories

제15장 전략적 제안

제16장 당사에 대해 & 면책사항

LSH 21.01.07

List of Figures

  • Figure 1: Global Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 2: Global Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 3: Global Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 4: Global Glycobiology Market Shar, By Product, By Instruments, By Value, 2015-2025F
  • Figure 5: Global Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 6: Global Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 7: Global Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 8: Global Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 9: Global Glycobiology Market Share, By Company, By Value, 2019
  • Figure 10: Global Glycobiology Market Share, By Region, By Value, 2019 & 2025F
  • Figure 11: Global Glycobiology Market Map, By Product - Market Size (USD Million) & Growth Rate (%)
  • Figure 12: Global Glycobiology Market Map, By Application - Market Size (USD Million) & Growth Rate (%)
  • Figure 13: Global Glycobiology Market Map, By End User - Market Size (USD Million) & Growth Rate (%)
  • Figure 14: Global Glycobiology Market Map, By Region - Market Size (USD Million) & Growth Rate (%)
  • Figure 15: North America Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 16: North America Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 17: North America Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 18: North America Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 19: North America Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 20: North America Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 21: North America Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 22: North America Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 23: North America Glycobiology Market Share, By Country, By Value, 2015-2025F
  • Figure 24: United States Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 25: New Cancer Cases in United States, (%), 2019
  • Figure 26: United States Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 27: United States Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 28: United States Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 29: United States Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 30: United States Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 31: United States Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 32: United States Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 33: Canada Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 34: Canada Hospital Establishments, By Region, 2019 (Units)
  • Figure 35: Canada Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 36: Canada Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 37: Canada Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 38: Canada Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 39: Canada Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 40: Canada Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 41: Canada Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 42: Mexico Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 43: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 44: Mexico Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 45: Mexico Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 46: Mexico Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 47: Mexico Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 48: Mexico Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 49: Mexico Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 50: Mexico Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 51: Europe Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 52: Europe Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 53: Europe Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 54: Europe Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 55: Europe Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 56: Europe Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 57: Europe Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 58: Europe Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 59: Europe Glycobiology Market Share, By Country, By Value, 2015-2025F
  • Figure 60: Germany Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 61: Number of Employees in the German Bio and Laboratory Technologies Industry, (Thousand), 2015-2019
  • Figure 62: Germany Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 63: Germany Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 64: Germany Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 65: Germany Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 66: Germany Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 67: Germany Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 68: Germany Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 69: United Kingdom Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 70: Geriatric Population Numbers & Projections in United Kingdom (Millions), 2019
  • Figure 71: United Kingdom Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 72: United Kingdom Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 73: United Kingdom Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 74: United Kingdom Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 75: United Kingdom Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 76: United Kingdom Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 77: United Kingdom Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 78: France Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 79: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
  • Figure 80: France Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 81: France Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 82: France Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 83: France Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 84: France Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 85: France Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 86: France Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 87: Italy Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 88: New Cancer Cases in Italy (%), Males, All Ages, 2019
  • Figure 89: Italy Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 90: Italy Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 91: Italy Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 92: Italy Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 93: Italy Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 94: Italy Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 95: Italy Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 96: Spain Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 97: Total Number of Hospitals in Spain, 2019
  • Figure 98: Spain Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 99: Spain Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 100: Spain Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 101: Spain Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 102: Spain Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 103: Spain Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 104: Spain Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 105: Asia Pacific Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 106: Asia Pacific Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 107: Asia Pacific Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 108: Asia Pacific Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 109: Asia Pacific Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 110: Asia Pacific Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 111: Asia Pacific Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 112: Asia Pacific Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 113: Asia-Pacific Glycobiology Market Share, By Country, By Value, 2015-2025F
  • Figure 114: China Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 115: New Cancer Cases in China (%), 2019
  • Figure 116: China Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 117: China Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 118: China Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 119: China Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 120: China Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 121: China Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 122: China Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 123: Japan Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 124: Japan Total Health Expenditure as a Share of GDP (%), 2015-2019
  • Figure 125: Japan Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 126: Japan Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 127: Japan Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 128: Japan Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 129: Japan Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 130: Japan Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 131: Japan Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 132: South Korea Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 133: New Cancer Cases in South Korea (%), 2019
  • Figure 134: South Korea Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 135: South Korea Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 136: South Korea Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 137: South Korea Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 138: South Korea Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 139: South Korea Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 140: South Korea Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 141: Australia Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 142: % of Public and Private Hospitals in Australia, 2019
  • Figure 143: Australia Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 144: Australia Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 145: Australia Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 146: Australia Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 147: Australia Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 148: Australia Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 149: Australia Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 150: India Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 151: Age Wise Prevalence of Breast Cancer in India, (%), Out of 100 Patients, 2019
  • Figure 152: India Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 153: India Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 154: India Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 155: India Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 156: India Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 157: India Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 158: India Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 159: South America Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 160: South America Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 161: South America Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 162: South America Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 163: South America Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 164: South America Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 165: South America Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 166: South America Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 167: South America Glycobiology Market Share, By Country, By Value, 2015-2025F
  • Figure 168: Brazil Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 169: Total Number of Hospitals in Brazil, 2015-2019
  • Figure 170: Brazil Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 171: Brazil Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 172: Brazil Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 173: Brazil Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 174: Brazil Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 175: Brazil Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 176: Brazil Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 177: Argentina Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 178: Argentina Health Expenditure (% of GDP), 2015-2019
  • Figure 179: Argentina Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 180: Argentina Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 181: Argentina Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 182: Argentina Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 183: Argentina Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 184: Argentina Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 185: Argentina Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 186: Colombia Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 187: % of Public and Private Hospitals in Colombia, 2019
  • Figure 188: Colombia Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 189: Colombia Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 190: Colombia Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 191: Colombia Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 192: Colombia Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 193: Colombia Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 194: Colombia Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 195: Middle East & Africa Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 196: Middle East & Africa Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 197: Middle East & Africa Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 198: Middle East & Africa Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 199: Middle East & Africa Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 200: Middle East & Africa Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 201: Middle East & Africa Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 202: Middle East & Africa Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 203: Middle East and Africa Glycobiology Market Share, By Country, By Value, 2015-2025F
  • Figure 204: UAE Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 205: UAE Health Expenditure (% of GDP), 2015-2019
  • Figure 206: UAE Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 207: UAE Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 208: UAE Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 209: UAE Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 210: UAE Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 211: UAE Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 212: UAE Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 213: Saudi Arabia Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 214: Total Number of Hospitals in Saudi Arabia, 2015-2019
  • Figure 215: Saudi Arabia Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 216: Saudi Arabia Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 217: Saudi Arabia Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 218: Saudi Arabia Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 219: Saudi Arabia Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 220: Saudi Arabia Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 221: Saudi Arabia Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 222: South Africa Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 223: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 224: South Africa Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 225: South Africa Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 226: South Africa Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 227: South Africa Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 228: South Africa Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 229: South Africa Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 230: South Africa Glycobiology Market Share, By End User, By Value, 2015-2025F
  • Figure 231: Kuwait Glycobiology Market Size, By Value, 2015-2025F (USD Million)
  • Figure 232: Kuwait Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 233: Kuwait Glycobiology Market Share, By Product, By Value, 2015-2025F
  • Figure 234: Kuwait Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
  • Figure 235: Kuwait Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
  • Figure 236: Kuwait Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
  • Figure 237: Kuwait Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
  • Figure 238: Kuwait Glycobiology Market Share, By Application, By Value, 2015-2025F
  • Figure 239: Kuwait Glycobiology Market Share, By End User, By Value, 2015-2025F

Title:
Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition, Forecast & Opportunities, 2025.

Global glycobiology market was valued at USD 938.76 Million in 2019 and is expected to grow at a double digit CAGR of 13.83% during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of market during the forecast period. Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of market over the next few years. Furthermore, increasing research activities in glycomics, technological advancements and rising government initiatives is also among the major drivers for the global glycobiology market.

The global glycobiology market is segmented based on product, application, end user, company, and region. Based on by product, the market can be categorized into enzymes, instruments, reagents, and kits. Among the following, enzymes contribute the majority of share in the market nearly about 35%. Based on by enzymes, they can be further bifurcated into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is leading the market is expected to dominate the market during the forecast period as well. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research. Based on by instruments, the market is fragmented into HPLC, mass spectrometry, MALDI-TOF, antibody arrays, lectin arrays, and others. The HPLC segment is attributed to dominate the market in the coming years. Based on by reagents, the market is segmented into glycoproteins, oligosaccharides, monosaccharides, and others. Based on by kits, the glycobiology market is sub-segmented into glycan releasing kit, glycan purification kit, glycan labeling kit, and others.

Regionally, the glycobiology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast period in the overall glycobiology market owing to the presence of many research laboratories and pharmaceutical and biotechnology companies in the region.

Major players operating in the global glycobiology market include Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Glycotope GmbH, Danaher Corporation, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Bio-Rad Laboratories and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments. For instance, in 2018, Shimadzu Corp. collaborated with premier Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global glycobiology market from 2015 to 2018.
  • To estimate and forecast the market size of global glycobiology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global glycobiology market based on type of enzyme, type of kit, application, end user, company and regional distribution.
  • To identify dominant region or segment in the global glycobiology market.
  • To identify drivers and challenges for global glycobiology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global glycobiology market.
  • To identify and analyze the profile of leading players operating in global glycobiology market.
  • To identify key sustainable strategies adopted by market players in global glycobiology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers of enzymes, kits & instruments used in glycobiology technique across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers of enzymes, kits & instruments used in glycobiology techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers of enzymes, kits & instruments used in glycobiology techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global glycobiology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Glycobiology enzymes, kits & instruments, manufacturers, suppliers, distributorsand other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to glycobiology
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers of enzymes, kits & instruments used in glycobiology techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global glycobiology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Glycobiology Market, By Product:

Enzymes

Instruments

Reagents

Kits

  • Global Glycobiology Market, By Enzyme:

Glycosidases & Neuramidases

Glycosyltransferases & Sialytransferases

Carbohydrate Kinases

Carbohydrate Sulfotransferases

Protein Sulfotransferases

Others

  • Global Glycobiology Market, By Instruments:

HPLC

Antibody arrays

Lectin arrays

MALDI-TOF

Mass spectroscopy

Others

  • Global Glycobiology Market, By Kit:

Glycan Releasing Kit

Glycan Labelling Kit

Glycan Purification Kit

Others

  • Global Glycobiology Market, By Application:

Drug Discovery

Disease Diagnostics

Virology

Cell Biology

Oncology

Others

  • Global Glycobiology Market, By End User:

Research Institutes

Diagnostic Centers

Hospitals

Clinical Laboratories

Pharmaceutical & Biotechnology Companies

Others

  • Global Glycobiology Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • South Korea
  • Australia
  • India

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • South Africa
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global glycobiology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Glycobiology Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. By Application
  • 5.3. Factors driving the Glycobiology Market

6. Global Glycobiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Enzymes, Instruments, Reagents and Kits)
      • 6.2.1.1. By Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
      • 6.2.1.2. By Instruments (HPLC, Antibody arrays, Lectin arrays, MALDI-TOF, Mass spectroscopy, Others)
      • 6.2.1.3. By Reagents (Monosaccharides, Glycoproteins, Oligosaccharides, Others)
      • 6.2.1.4. By Kits (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
    • 6.2.2. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
    • 6.2.3. By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Product Market Map

7. North America Glycobiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
      • 7.2.1.1. By Enzymes
      • 7.2.1.2. By Instruments
      • 7.2.1.3. By Reagents
      • 7.2.1.4. By Kits
    • 7.2.2. Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Glycobiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.1.1. By Enzymes
        • 7.3.1.2.1.2. By Instruments
        • 7.3.1.2.1.3. By Reagents
        • 7.3.1.2.1.4. By Kits
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Glycobiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.1.1. By Enzymes
        • 7.3.2.2.1.2. By Instruments
        • 7.3.2.2.1.3. By Reagents
        • 7.3.2.2.1.4. By Kits
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Glycobiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.1.1. By Enzymes
        • 7.3.3.2.1.2. By Instruments
        • 7.3.3.2.1.3. By Reagents
        • 7.3.3.2.1.4. By Kits
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Glycobiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
      • 8.2.1.1. By Enzymes
      • 8.2.1.2. By Instruments
      • 8.2.1.3. By Reagents
      • 8.2.1.4. By Kits
    • 8.2.2. Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Glycobiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.1.1. By Enzymes
        • 8.3.1.2.1.2. By Instruments
        • 8.3.1.2.1.3. By Reagents
        • 8.3.1.2.1.4. By Kits
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. United Kingdom Glycobiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.1.1. By Enzymes
        • 8.3.2.2.1.2. By Instruments
        • 8.3.2.2.1.3. By Reagents
        • 8.3.2.2.1.4. By Kits
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. France Glycobiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.1.1. By Enzymes
        • 8.3.3.2.1.2. By Instruments
        • 8.3.3.2.1.3. By Reagents
        • 8.3.3.2.1.4. By Kits
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Glycobiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.1.1. By Enzymes
        • 8.3.4.2.1.2. By Instruments
        • 8.3.4.2.1.3. By Reagents
        • 8.3.4.2.1.4. By Kits
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Glycobiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.1.1. By Enzymes
        • 8.3.5.2.1.2. By Instruments
        • 8.3.5.2.1.3. By Reagents
        • 8.3.5.2.1.4. By Kits
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia Pacific Glycobiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
  • 9.3. Market Share & Forecast
    • 9.3.1. By Product
      • 9.3.1.1. By Enzymes
      • 9.3.1.2. By Instruments
      • 9.3.1.3. By Reagents
      • 9.3.1.4. By Kits
    • 9.3.2. Application
    • 9.3.3. By End User
    • 9.3.4. By Country
  • 9.4. Asia Pacific: Country Analysis
    • 9.4.1. China Glycobiology Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Product
        • 9.4.1.2.1.1. By Enzymes
        • 9.4.1.2.1.2. By Instruments
        • 9.4.1.2.1.3. By Reagents
        • 9.4.1.2.1.4. By Kits
        • 9.4.1.2.2. By Application
        • 9.4.1.2.3. By End User
    • 9.4.2. Japan Glycobiology Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Product
        • 9.4.2.2.1.1. By Enzymes
        • 9.4.2.2.1.2. By Instruments
        • 9.4.2.2.1.3. By Reagents
        • 9.4.2.2.1.4. By Kits
        • 9.4.2.2.2. By Application
        • 9.4.2.2.3. By End User
    • 9.4.3. South Korea Glycobiology Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Product
        • 9.4.3.2.1.1. By Enzymes
        • 9.4.3.2.1.2. By Instruments
        • 9.4.3.2.1.3. By Reagents
        • 9.4.3.2.1.4. By Kits
        • 9.4.3.2.2. By Application
        • 9.4.3.2.3. By End User
    • 9.4.4. Australia Glycobiology Market Outlook
      • 9.4.4.1. Market Size & Forecast
        • 9.4.4.1.1. By Value
      • 9.4.4.2. Market Share & Forecast
        • 9.4.4.2.1. By Product
        • 9.4.4.2.1.1. By Enzymes
        • 9.4.4.2.1.2. By Instruments
        • 9.4.4.2.1.3. By Reagents
        • 9.4.4.2.1.4. By Kits
        • 9.4.4.2.2. By Application
        • 9.4.4.2.3. By End User
    • 9.4.5. India Glycobiology Market Outlook
      • 9.4.5.1. Market Size & Forecast
        • 9.4.5.1.1. By Value
      • 9.4.5.2. Market Share & Forecast
        • 9.4.5.2.1. By Product
        • 9.4.5.2.1.1. By Enzymes
        • 9.4.5.2.1.2. By Instruments
        • 9.4.5.2.1.3. By Reagents
        • 9.4.5.2.1.4. By Kits
        • 9.4.5.2.2. By Application
        • 9.4.5.2.3. By End User

10. South America Glycobiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
      • 10.2.1.1. By Enzymes
      • 10.2.1.2. By Instruments
      • 10.2.1.3. By Reagents
      • 10.2.1.4. By Kits
    • 10.2.2. Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Glycobiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.1.1. By Enzymes
        • 10.3.1.2.1.2. By Instruments
        • 10.3.1.2.1.3. By Reagents
        • 10.3.1.2.1.4. By Kits
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Glycobiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.1.1. By Enzymes
        • 10.3.2.2.1.2. By Instruments
        • 10.3.2.2.1.3. By Reagents
        • 10.3.2.2.1.4. By Kits
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Glycobiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.1.1. By Enzymes
        • 10.3.3.2.1.2. By Instruments
        • 10.3.3.2.1.3. By Reagents
        • 10.3.3.2.1.4. By Kits
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Glycobiology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type of Enzyme
    • 11.2.2. By Type of Kit
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. UAE Glycobiology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.1.1. By Enzymes
        • 11.3.1.2.1.2. By Instruments
        • 11.3.1.2.1.3. By Reagents
        • 11.3.1.2.1.4. By Kits
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Glycobiology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.1.1. By Enzymes
        • 11.3.2.2.1.2. By Instruments
        • 11.3.2.2.1.3. By Reagents
        • 11.3.2.2.1.4. By Kits
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. South Africa Glycobiology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.1.1. By Enzymes
        • 11.3.3.2.1.2. By Instruments
        • 11.3.3.2.1.3. By Reagents
        • 11.3.3.2.1.4. By Kits
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User
    • 11.3.4. Kuwait Glycobiology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.1.1. By Enzymes
        • 11.3.4.2.1.2. By Instruments
        • 11.3.4.2.1.3. By Reagents
        • 11.3.4.2.1.4. By Kits
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Merck & Co., Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Thermo Fisher Scientific
  • 14.4. New England Biolabs, Inc.
  • 14.5. Shimadzu Corporation
  • 14.6. Takara Bio Inc.
  • 14.7. Waters Corporation
  • 14.8. Asparia Glycomics S.L.
  • 14.9. Bruker Corporation
  • 14.10. RayBiotech, Inc.
  • 14.11. Z Biotech, LLC.
  • 14.12. Chemily Glycoscience
  • 14.13. Dextra Laboratories Ltd.
  • 14.14. Lectenz Bio
  • 14.15. Ludger Ltd
  • 14.16. R&D Systems, Inc.
  • 14.17. Glycotope GmbH
  • 14.18. Danaher Corporation
  • 14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • 14.20. Bio-Rad Laboratories

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q